Cytori Therapeutics Inc (CYTX)-Medical Equipment-Deals and Alliances Profile

Cytori Therapeutics Inc (CYTX)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME4264D
  • |
  • Pages: 39
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cytori Therapeutics Inc (Cytori) is a clinical stage regenerative medicine company. It develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) for the treatment of cardiovascular disease, orthopedic conditions and gastrointestinal disorders. The company has two therapeutic development platforms namely, Cytori Cell Therapy (CCT) and Cytori Nanomedicine. Cytori uses CCT platform based on the scientific discovery to develop variety of therapies with focus on the treatment of impaired hand function in scleroderma. The Cytori Nanomedicine is a versatile and novel protein-stabilized liposomal nanoparticle technology used for drug encapsulation. The company offers its products to the physicians, researchers, hospitals, clinics and other customers for commercial and research purposes. Cytori is headquartered in San Diego, California, the US.

Cytori Therapeutics Inc (CYTX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Cytori Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Cytori Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Cytori Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Cytori Therapeutics Inc, Medical Equipment, Deal Details 11

Partnerships 11

Human Stem Cells Institute Enters into Co-Marketing Agreement with Cytori Therapeutics for Celution System 11

Cytori Therapeutics Enters Into Licensing Agreement With Lorem Vascular 11

Cytori Therapeutics Enters Into Licensing Agreement With Bimini Technologies For Celution 12

Equity Offering 13

Cytori Therapeutics Plans to Raise Funds through Public Offering of Shares 13

Cytori Therapeutics to Raise up to USD20 Million in Private Placement of Shares 14

Cytori Therapeutics Prices Private Placement of Units for USD25 Million 15

Cytori Therapeutics Raises USD10 Million in Private Placement of Units 17

Cytori Therapeutics Completes Public Offering Of Shares For US$23 Million 18

Cytori Therapeutics Completes Private Placement Of Shares For US$18.2 Million 19

Asset Transactions 20

Bimini Technologies Acquires Puregraft Rights From Cytori Therapeutics For Up To US$15 Million 20

Acquisition 22

Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 22

Cytori Therapeutics Inc-Key Competitors 23

Key Employees 24

Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Financial Announcements 26

May 11, 2017: Cytori Reports First Quarter 2017 Business and Financial Results 26

Mar 23, 2017: Cytori Reports Fourth Quarter and Full Year 2016 Business and Financial Results 27

Nov 09, 2016: Cytori Reports Third Quarter 2016 Business and Financial Results 28

Aug 04, 2016: Cytori Reports Second Quarter 2016 Business and Financial Results 29

May 10, 2016: Cytori Reports First Quarter 2016 Business and Financial Results 31

Mar 03, 2016: Cytori Reports Fourth Quarter and Full Year 2015 Business and Financial Results 32

Corporate Communications 33

Apr 03, 2017: Cytori Appoints Gregg Lapointe to Board of Directors 33

Dec 28, 2016: Ronald Martell to Join Cytori Therapeutics' Board of Directors 34

Product News 35

Jun 01, 2017: Cytori to Introduce Next-Generation Celution Technology 35

Jun 08, 2016: Presentation of Twelve Month Pilot Trial Data of Cytori Cell Therapy for ACL Reconstruction 36

Feb 08, 2016: Cytori Reports Interim Data on U.S. Phase II Osteoarthritis Trial 37

Other Significant Developments 38

Jun 08, 2017: Long Term Safety Data Published on Cytori Technology for Breast Reconstruction After Oncologic Surgery & Radiation Therapy 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39

List of Figures

Cytori Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Cytori Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Cytori Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Cytori Therapeutics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Cytori Therapeutics Inc, Medical Equipment, Key Facts, 2016 1

Cytori Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Cytori Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Cytori Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Cytori Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Cytori Therapeutics Inc, Deals By Market, 2011 to YTD 2017 9

Cytori Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Human Stem Cells Institute Enters into Co-Marketing Agreement with Cytori Therapeutics for Celution System 11

Cytori Therapeutics Enters Into Licensing Agreement With Lorem Vascular 11

Cytori Therapeutics Enters Into Licensing Agreement With Bimini Technologies For Celution 12

Cytori Therapeutics Plans to Raise Funds through Public Offering of Shares 13

Cytori Therapeutics to Raise up to USD20 Million in Private Placement of Shares 14

Cytori Therapeutics Prices Private Placement of Units for USD25 Million 15

Cytori Therapeutics Raises USD10 Million in Private Placement of Units 17

Cytori Therapeutics Completes Public Offering Of Shares For US$23 Million 18

Cytori Therapeutics Completes Private Placement Of Shares For US$18.2 Million 19

Bimini Technologies Acquires Puregraft Rights From Cytori Therapeutics For Up To US$15 Million 20

Cytori Therapeutics Acquires Remaining 50% Stake in Olympus-Cytori from Olympus 22

Cytori Therapeutics Inc, Key Competitors 23

Cytori Therapeutics Inc, Key Employees 24

Cytori Therapeutics Inc, Other Locations 25

Cytori Therapeutics Inc, Subsidiaries 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Cytori Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16005
Site License
USD 500 INR 32010
Corporate User License
USD 750 INR 48015

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com